1.
Psilocybin
Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward
Positive Relative to Negative Emotions Through Different Serotonergic
Subreceptors. Kometer
M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Biol
Psychiatry. 2012 May 9. [Epub ahead of print] PMID: 22578254
2.
High doses of
dextromethorphan, an NMDA antagonist, produce effects similar to classic
hallucinogens. Reissig
CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR.
Psychopharmacology
(Berl). 2012 Apr 13. [Epub ahead of print] PMID: 22526529
3.
Neuroimaging: a
scanner, colourfully. Roiser JP, Rees G. Curr Biol. 2012 Apr
10;22(7):R231-3. PMID: 22497939
4.
Prediction of psilocybin response in healthy
volunteers. Studerus
E, Gamma A, Kometer M, Vollenweider FX. PLoS One. 2012;7(2):e30800. Epub 2012
Feb 17. PMID: 22363492 Free PMC Article
5.
Hallucinogen
actions on human brain revealed. Lee HM, Roth BL. Proc Natl Acad Sci U S
A. 2012 Feb 7;109(6):1820-1. Epub 2012 Jan 30. No abstract available. PMID: 22308478
6.
Neural
correlates of the psychedelic state as determined by fMRI studies with psilocybin. Carhart-Harris
RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R,
Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ. Proc
Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43. Epub 2012 Jan 23. PMID: 22308440
7.
Implications for
psychedelic-assisted psychotherapy: functional magnetic resonance imaging study
with psilocybin. Carhart-Harris
RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp
DJ, Evans J, Feilding A, Wise RG, Nutt DJ. Br J Psychiatry. 2012
Mar;200(3):238-44. Epub 2012 Jan 26. PMID: 22282432
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.